Wolverine Trading
ABMD

Wolverine Trading’s Abiomed Inc ABMD Stock Holding History

Wolverine Trading’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,600
Closed -$923K – 5638
2022
Q2 		$923K Sell
3,600
-2,200
-38% -$594K ﹤0.01% 1995
2022
Q1 		$1.91M Buy
+5,800
New +$1.79M ﹤0.01% 1810
2021
Q4 		– Sell
-8,700
Closed -$2.87M – 7240
2021
Q3 		$2.87M Buy
+8,700
New +$2.95M ﹤0.01% 1772
2021
Q2 		– Sell
-10,900
Closed -$3.38M – 7000
2021
Q1 		$3.38M Sell
10,900
-28,900
-73% -$9.25M 0.01% 1434
2020
Q4 		$12.9M Sell
39,800
-2,400
-6% -$664K 0.02% 567
2020
Q3 		$11.5M Sell
42,200
-3,600
-8% -$1.04M 0.03% 480
2020
Q2 		$11M Sell
45,800
-6,100
-12% -$1.22M 0.03% 430
2020
Q1 		$7.73M Sell
51,900
-24,800
-32% -$4.12M 0.02% 542
2019
Q4 		$12.8M Buy
76,700
+11,000
+17% +$2.04M 0.03% 559
2019
Q3 		$11.6M Sell
65,700
-2,900
-4% -$627K 0.03% 462
2019
Q2 		$17.9M Buy
68,600
+14,300
+26% +$3.79M 0.05% 322
2019
Q1 		$15.5M Buy
54,300
+11,400
+27% +$3.79M 0.05% 333
2018
Q4 		$13.6M Sell
42,900
-400
-0.9% -$139K 0.04% 362
2018
Q3 		$19.5M Buy
43,300
+25,600
+145% +$10.1M 0.04% 310
2018
Q2 		$5.15M Hold
17,700
– – 0.01% 856
2018
Q1 		$5.15M Buy
+17,700
New +$4.49M 0.01% 856
2017
Q3 		– Sell
-28,800
Closed -$4.04M – 5243
2017
Q2 		$4.04M Buy
+28,800
New +$3.87M 0.02% 795
2016
Q4 		– Sell
-34,700
Closed -$4.46M – 5371
2016
Q3 		$4.46M Buy
+34,700
New +$4.16M 0.02% 801

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Wolverine Trading's ABMD Position: Q4 2021 in Review

Wolverine Trading sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 6,430 shares — an estimated $2.12M sold.

Wolverine Trading first reported a position in ABMD in Q3 2016 and held it in 15 quarters. The position peaked at $23.1M in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Wolverine Trading reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 6,430 Abiomed Inc shares in Q4 2021, an estimated $2.12M.
  • Wolverine Trading first reported a position in Abiomed Inc in Q3 2016 and held it in 15 quarters.
  • Wolverine Trading's Abiomed Inc position peaked at $23.1M in Q3 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.